These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. De novo loss-of-function KCNMA1 variants are associated with a new multiple malformation syndrome and a broad spectrum of developmental and neurological phenotypes. Liang L; Li X; Moutton S; Schrier Vergano SA; Cogné B; Saint-Martin A; Hurst ACE; Hu Y; Bodamer O; Thevenon J; Hung CY; Isidor B; Gerard B; Rega A; Nambot S; Lehalle D; Duffourd Y; Thauvin-Robinet C; Faivre L; Bézieau S; Dure LS; Helbling DC; Bick D; Xu C; Chen Q; Mancini GMS; Vitobello A; Wang QK Hum Mol Genet; 2019 Sep; 28(17):2937-2951. PubMed ID: 31152168 [TBL] [Abstract][Full Text] [Related]
28. Phenotypic spectrum of GNAO1 variants: epileptic encephalopathy to involuntary movements with severe developmental delay. Saitsu H; Fukai R; Ben-Zeev B; Sakai Y; Mimaki M; Okamoto N; Suzuki Y; Monden Y; Saito H; Tziperman B; Torio M; Akamine S; Takahashi N; Osaka H; Yamagata T; Nakamura K; Tsurusaki Y; Nakashima M; Miyake N; Shiina M; Ogata K; Matsumoto N Eur J Hum Genet; 2016 Jan; 24(1):129-34. PubMed ID: 25966631 [TBL] [Abstract][Full Text] [Related]
29. Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmorphic features. Niturad CE; Lev D; Kalscheuer VM; Charzewska A; Schubert J; Lerman-Sagie T; Kroes HY; Oegema R; Traverso M; Specchio N; Lassota M; Chelly J; Bennett-Back O; Carmi N; Koffler-Brill T; Iacomino M; Trivisano M; Capovilla G; Striano P; Nawara M; Rzonca S; Fischer U; Bienek M; Jensen C; Hu H; Thiele H; Altmüller J; Krause R; May P; Becker F; ; Balling R; Biskup S; Haas SA; Nürnberg P; van Gassen KLI; Lerche H; Zara F; Maljevic S; Leshinsky-Silver E Brain; 2017 Nov; 140(11):2879-2894. PubMed ID: 29053855 [TBL] [Abstract][Full Text] [Related]
30. Characterization of a Long Non-Coding RNA, the Antisense RNA of Na/K-ATPase α1 in Human Kidney Cells. Fan X; Ashraf UM; Drummond CA; Shi H; Zhang X; Kumarasamy S; Tian J Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30037072 [TBL] [Abstract][Full Text] [Related]
31. Case Report: A Novel Wei Y; Qian M Front Pediatr; 2021; 9():604105. PubMed ID: 33718295 [No Abstract] [Full Text] [Related]
32. Novel De Novo Mutations in KIF1A as a Cause of Hereditary Spastic Paraplegia With Progressive Central Nervous System Involvement. Hotchkiss L; Donkervoort S; Leach ME; Mohassel P; Bharucha-Goebel DX; Bradley N; Nguyen D; Hu Y; Gurgel-Giannetti J; Bönnemann CG J Child Neurol; 2016 Aug; 31(9):1114-9. PubMed ID: 27034427 [TBL] [Abstract][Full Text] [Related]
33. GRIN1 mutations cause encephalopathy with infantile-onset epilepsy, and hyperkinetic and stereotyped movement disorders. Ohba C; Shiina M; Tohyama J; Haginoya K; Lerman-Sagie T; Okamoto N; Blumkin L; Lev D; Mukaida S; Nozaki F; Uematsu M; Onuma A; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Tanaka F; Kato M; Ogata K; Saitsu H; Matsumoto N Epilepsia; 2015 Jun; 56(6):841-8. PubMed ID: 25864721 [TBL] [Abstract][Full Text] [Related]
34. Pathogenic heterozygous TRPM7 variants and hypomagnesemia with developmental delay. Bosman W; Butler KM; Chang CA; Ganapathi M; Guzman E; Latta F; Chung WK; Claverie-Martin F; Davis JM; Hoenderop JGJ; de Baaij JHF Clin Kidney J; 2024 Aug; 17(8):sfae211. PubMed ID: 39099563 [TBL] [Abstract][Full Text] [Related]
35. Refining Genotypes and Phenotypes in Döring JH; Schröter J; Jüngling J; Biskup S; Klotz KA; Bast T; Dietel T; Korenke GC; Christoph S; Brennenstuhl H; Rubboli G; Møller RS; Lesca G; Chaix Y; Kölker S; Hoffmann GF; Lemke JR; Syrbe S Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802230 [TBL] [Abstract][Full Text] [Related]
36. A Novel De Novo TUBB3 Variant Causing Developmental Delay, Epilepsy and Mild Ophthalmological Symptoms in a Chinese Child. Xue J; Song Z; Ma S; Yi Z; Yang C; Li F; Liu K; Zhang Y J Mol Neurosci; 2022 Jan; 72(1):37-44. PubMed ID: 34562182 [TBL] [Abstract][Full Text] [Related]
37. De Novo Variants in CNOT1, a Central Component of the CCR4-NOT Complex Involved in Gene Expression and RNA and Protein Stability, Cause Neurodevelopmental Delay. Vissers LELM; Kalvakuri S; de Boer E; Geuer S; Oud M; van Outersterp I; Kwint M; Witmond M; Kersten S; Polla DL; Weijers D; Begtrup A; McWalter K; Ruiz A; Gabau E; Morton JEV; Griffith C; Weiss K; Gamble C; Bartley J; Vernon HJ; Brunet K; Ruivenkamp C; Kant SG; Kruszka P; Larson A; Afenjar A; Billette de Villemeur T; Nugent K; ; Raymond FL; Venselaar H; Demurger F; Soler-Alfonso C; Li D; Bhoj E; Hayes I; Hamilton NP; Ahmad A; Fisher R; van den Born M; Willems M; Sorlin A; Delanne J; Moutton S; Christophe P; Mau-Them FT; Vitobello A; Goel H; Massingham L; Phornphutkul C; Schwab J; Keren B; Charles P; Vreeburg M; De Simone L; Hoganson G; Iascone M; Milani D; Evenepoel L; Revencu N; Ward DI; Burns K; Krantz I; Raible SE; Murrell JR; Wood K; Cho MT; van Bokhoven H; Muenke M; Kleefstra T; Bodmer R; de Brouwer APM Am J Hum Genet; 2020 Jul; 107(1):164-172. PubMed ID: 32553196 [TBL] [Abstract][Full Text] [Related]
38. Recurrent de novo WFS1 pathogenic variants in Chinese sporadic patients with nonsyndromic sensorineural hearing loss. Guan J; Wang H; Lan L; Wu Y; Chen G; Zhao C; Wang D; Wang Q Mol Genet Genomic Med; 2020 Aug; 8(8):e1367. PubMed ID: 32567228 [TBL] [Abstract][Full Text] [Related]
39. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities. Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881 [TBL] [Abstract][Full Text] [Related]
40. Early-onset infant epileptic encephalopathy associated with a de novo Qian Y; Wu B; Lu Y; Dong X; Qin Q; Zhou W; Wang H Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30455226 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]